Codexis (CDXS) Invested Capital (2019 - 2026)
Codexis (CDXS) posted quarterly Invested Capital of $9000.0 for Q1 2020, down 96.28% year-over-year from $242000.0 in Q2 2019, and down 85.0% quarter-over-quarter from $60000.0 in Q4 2019.
Codexis (CDXS) Invested Capital (2019 - 2026) Analysis & Trends
Codexis' Invested Capital history runs 2 years deep, the most recent figure standing at $9000.0 for Q1 2020.
- In Q1 2020, Invested Capital fell 96.28% year-over-year to $9000.0; the TTM figure through Dec 2020 stood at $9000.0 (down 98.52% YoY), while the FY2019 annual figure was $60000.0, changed N/A from the prior year.
- Invested Capital for Q1 2020 stood at $9000.0, down from $60000.0 in the prior quarter.
- The five-year high for Invested Capital was $242000.0 in Q1 2019, with the low at $9000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 7.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.06 Mn |
| Mar 31, 2020 | 9,000.00 |
| Dec 31, 2019 | 60,000.00 |
| Sep 30, 2019 | 122,000.00 |
| Jun 30, 2019 | 183,000.00 |
| Mar 31, 2019 | 242,000.00 |